Trial Profile
A single centre, double-blind, randomized, 2-way crossover study to investigate the effect of up-titration regimen of ponesimod on cardiovascular safety and tolerability
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs Ponesimod (Primary)
- Indications Graft-versus-host disease; Immunological disorders; Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Actelion Pharmaceuticals
- 05 Nov 2015 New trial record